Synthesis and characterization of Cu (II) complexes of salicylate ligands by Ogodo, U.P. & Abosede, O.O.
 
*Corresponding Author Email: abosedeoo@fuotuoke.edu.ng 
 
PRINT ISSN 1119-8362 




J. Appl. Sci. Environ. Manage.  
Vol. 22 (12) 1961–1964 December 2018 
Full-text Available Online at 
https://www.ajol.info/index.php/jasem 
http://ww.bioline.org.br/ja 
Synthesis and Characterization of Cu (II) Complexes of Salicylate Ligands 
 
OGODO, UP; *ABOSEDE, OO 
 
Department of Chemistry, Federal University Otuoke, P.M.B 126, Yenagoa, Bayelsa State, Nigeria. 
*Corresponding Author Email: abosedeoo@fuotuoke.edu.ng 
 
ABSTRACT: This work evaluates the synthesis and characterization of Cu (II) complexes of salicylate ligands using 
green method. The complexes were synthesized by direct mixing of the metal salt (CuCO3) dissolved in water and a 
corresponding ligand dissolved also in water. The complex was obtained in excellent yields (80%) by moderate heating 
in distilled water. The complexes were characterized by Ultra-Violet Spectrophotometer (UV-Vis), solubility, melting 
point and X-ray diffraction. Metal complex with formula of Cu (II)-L2 where L = acetylsalicylic acid and salicylic acid 
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Drugs are natural or synthetic substances which (when 
taken into a living body) affects its functioning or 
structure, and is used in the diagnosis, mitigation, 
treatment, or prevention of a disease or relief of 
discomfort.  (cis-[Pt(NH3)2Cl2]) which is used in the 
treatment of tumor was accidentally discovered by 
Barnett Rosenberg in the 1960s when he was studying 
the resemblance between the mitotic spindle of 
dividing cells and the orientation of iron filing around 
a magnetic field (Alderden et al., 2006; Fricker, 2007; 
Kiremire, 2010). The discovery and development of 
the antitumor compound cisplatin and its analogues 
played a very important role in the establishment of 
the field of medicinal inorganic chemistry (Fricker, 
2007).  Since the discovery of cisplatin there has been 
an upsurge in research in the field of metal-based 
therapeutics. 
 
Fig 1. Structure of Cisplatin 
 
Salicylate ligands (salH and ASA) are well-known 
class of drugs that are antipyretic, analgesic and anti-
inflammetory agents. They are found to be among the 
most consumed drugs over the world and are used in 
clinical practice of inflammatory disorders including 
cancer, arthritis as well as for prevention of 
myocardial infarction and pain relief (Kovala et al.,  
 
1998; Konstandinidou et al., 1998). Cu(II) complexes 
with  aspirin and other salicylic acid derivatives have 
been found to be more potent and desirable drugs than 
their constituent ligands (Jacka et al., 1983). Evidence 
of experimental research work by different researchers 
all over the world proved that the coordination of 
Cu(II) ion  by salicylate ligands  improves the potency, 
stability and other pharmaceutical activity of the drugs 
and reduce their undesired toxicity effects in human 
and veterinary medicine (O’Connor et al., 2012; 
Weiping et al., 1998). 
 
Fig 2. Structure of (a) acetylsalicylic acid and (b) salicylic acid              
 
There is a large amount of information available on the 
synthesis and characterization of metal chelates 
derived from copper and biologically important 
ligands, because of the usual improvement in the 
biological properties of parent ligands (Abosede et al., 
2016). However, the synthesis of these complexes has 
always been through non-benign routes. Therefore, the 
green synthesis of copper complexes of Salicylic acid 
(salH) and Acetlysalicylic acid (ASA) is of interest in 
order to evaluate their coordination chemistry and 
biological activity. 
 
MATERIALS AND METHODS 
Copper carbonate hydroxide, acetylsalicylic acid 
(ASA) and salicylic acid (salH) were obtained from 
commercial sources and were used without further 
purification. The melting points of the complexes were 
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determined using Stuart melting point (SMP 11) 
apparatus, while solubility was determined in 
analytical grade solvents: methanol, ethanol, distilled 
water and acetone. Electronic absorption spectra were 
taken on JASCO V-730 Ultraviolet Visible 
spectrophotometer and diffraction measurement was 
taken on Pananalytica X’pert X-ray diffractometer. 
 
 Synthesis of complexes of [Cu (II)(ASA)] (1) 
Complex: Copper carbonate hydroxide (0.122 g, 1 
mmol) was added to a 6 mL of hot distilled water in a 
round bottom flask (insoluble), set upon a heating 
mantle and heated for about 10 minutes. ASA (0.360 
g, 2 mmol) was added to the solution in the round 
bottom flask and continued heating. The mixture was 
refluxed on a water bath for 90 minutes. Greenish 
solution was formed upon dissolution of ASA. A 
greenish resulting solid complex 1 was collected by 
filtration and washed with 2 mL of hot water and was 
kept for 3 weeks to dry (Yield: 80%). (Abosede et al., 
2016)
 
Fig 3. Schematic synthesis of [Cu (II)(ASA)] Complex 
 
Synthesis of [Cu (II)(salH)2] Complex (2): Copper 
carbonate hydroxide (0.122 g, 1 mmol) was added to 
a 6 mL of hot distilled water in a round bottom flask 
(insoluble). It was set upon a heating mantle and was 
heated for about 10 minutes. salH (0.314 g, 2 mmol) 
was added to the solution in the round bottom flask.  
 
The mixture was refluxed on a water bath for about 20 
minutes. The resulting solid complex 2 was collected 
by filtration and washed with 2-3 mL of hot water and 
was kept for 3 weeks to dry. Green crystals of 2 were 
formed in the green filtrate after 3 weeks (Abosede et 
al., 2016).
 
Fig 4. Schematic synthesis of [Cu (II)(salH)2] 
 
RESULTS AND DISCUSSION 
The physical properties of the ligands and their metal 
complexes are given in Table 1. The absorption 
spectra of the complexes and their respective ligands 
were recorded in the range of 200-400 nm. The 
absorption spectra have been recorded in the mother 
liquor (water) prior to the precipitation of the isolated  
 
complexes. In aqueous solution, acetylsalicylic acid 
(ASA) had a single absorption peak at 275 nm while 
salicylic acid (salH) had two absorptions peaks at 230 
nm and 297 nm due to intraligand transition (π-π*) 
(Fig 5a). This absorbance was compared to that of the 
complexes formed. The electronic spectra of these 
ligands and their complexes were illustrated in Table 
1. 
 
Table 1. Physical and absorption characteristics of the ligands and copper complexes 
Compound  Colour Melting point oC Appearance Ligand transitions (nm) 
ASA White 110-130 Crystalline  275 
salH White 105-120 Crystalline 230 (sh*) & 297 
[Cu(ASA)2] Green  175-180 Crystalline 296 
[Cu(salH)2] Green 170-185 Crystalline 228 (sh)& 295 
CuCO3 Light green > 360 Powdery  ------ 
*sh = shoulder 
Table 2. Solubility of the ligands and metal complexes in different solvents 
Compound Distilled Water Ethanol Methanol Acetone 
Salicylic acid S1S S S S 
Acetylsalicylic acid S1S S S S 
Copper(II) carbonate I I I I 
[Cu(salH)2] I S S S 
[Cu(ASA)2] I S S S 
S1S = slightly soluble; S = soluble; I = insoluble; VS = very soluble 
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Fig 5. Absorption spectra of aqueous solution of (a) acetylsalicylic acid and its copper complex; (b) salicylic acid and its copper complex. 
The solubility results show that salH and ASA are 
slightly soluble in water and their metal complexes are 
insoluble. In other solvents used in the test, the 
solubility of the metal complexes showed a different 
pattern whereby their solubility varied from slightly 
soluble to being soluble. The copper complex with 
acetylsalicylic acid had a single peak at 296 nm (Fig 
5a) of the ultraviolet region, while copper complex 
with salicylic acid had two peaks at 228 nm and 295 
nm (Fig 5b). Complexes of [Cu(II)(ASA)2] and 
[Cu(II)(salH)2] also showed the absorption peaks of 
the ligands but with shifting comparing with the 
ligand; ASA absorption at 275 nm appears at 296 nm 
in [Cu(II)(ASA)2]; this corresponds to a red shift (from 
a lower wavelength to a higher wavelength), while 
salH and [Cu(II)(salH)2] had absorption at 297 nm and 
295 nm; this corresponds to a blue shift (from a higher 
wavelength to a lower wavelength). These changes in 
the absorption spectra confirm that both complexes 
were new products from acetylsalicylic acid and 
salicylic acid respectively. Furthermore, the X-ray 
diffraction pattern of [Cu(II)(ASA)2] (Fig 6) reveal 
that the complex has a crystalline morphology.
 
Fig 6. X-ray powder diffraction pattern of [Cu(II)(ASA)2]. 
 
Conclusion: In this research, two metal complexes of 
salicylic acid and its derivative (acetyl salicylic acid, 
aspirin) have been synthesized and characterized by 
UV-spectroscopy, solubility, melting point and X-ray 
powder diffraction (XRD). This work confirms the 
environmentally friendly synthesis of two metal 
complexes of copper viz: [Cu (II)(ASA)2] and 
[Cu(II)(salH)2] with the use of non-toxic solvent, 
water. This synthesis method is low cost and saves 
time. The spectra of the ligands and the complexes  
 
formed proved that new products were formed and are 
stable.  
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